Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centella asiatica is a perennial herb in the Apiaceae family, known for its use in traditional medicine across Asia and Africa for wound healing, skin disorders, and cognitive enhancement. Its pharmacological effects are attributed to compounds such as asiaticoside, madecassoside, triterpenes, carotenoids, and flavonoids. The plant is consumed both as a culinary ingredient and as an herbal remedy, found in a wide range of topical and oral preparations. Although widely used, it is not considered a canonical molecular target for drug development but a source of bioactive phytochemicals. In summary, Centella asiatica is a medicinal plant and not a molecule or receptor, and thus does not meet the criteria for a canonical therapeutic target. For target-specific information, isolate one of its active compounds (e.g., asiaticoside) rather than the plant name.
Compounds such as asiaticoside, madecassoside, and triterpene saponins act through collagen synthesis, anti-inflammatory pathways, neuroprotection, and immune modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centella asiatica.